Author Archives: Isaura Santos

Consortium Acts To Revive Drug Development Projects For Brain Diseases Such As Alzheimer’s

The Neurodegeneration Medicines Acceleration Program (Neuro-MAP) led by MRC Technology is a non-profit organization that brings together promising drug projects for brain diseases like Parkinson’s and Alzheimer’s that have stalled due to lack of support with funding organizations. Their goal is to revive these projects by helping scientists continue their…

Almost Half Of Alzheimer’s Family Caregivers Have $20,000 in Expenses Per Year

According to a Caring.com report, 42 percent of family members taking care of Alzheimer’s or dementia family members spend upwards of $20,000 or more per year. These care-giving expenses include out-of-pocket costs for assisted living, medications, medical bills, professional in-home caregivers, products for incontinence, wandering products, transportation, and more. Of…

Senior Care Organization Calls For Relationship-Based Care For Alzheimer’s Patients At G7 Global Dementia Legacy Event

Home Instead Senior Care (Home Instead SC) recently joined healthcare leaders from G7 governments for a general discussion regarding the progress made in community-based patient care initiatives and education as part of the Global Action against Dementia Legacy program. Home Instead’s president Jeff Huber and Duskin Company Home Instead Division Manager …

Brain Research Needs To Be Better Supported, Experts Say

In a special issue of the Cell Press journal Neuron, experts debated the challenges associated with “translational neuroscience,” and the efforts that should be made to commercialize advances made in the laboratory so that patients can benefit from them. Despite the major advances that science is making in understanding…

Type 2 Diabetes Drugs Can Help Reverse Alzheimer’s, Study Says

A new study published in the journal Neuropharmacology revealed that drugs used to treat type 2 diabetes can actually help to reverse Alzheimer’s disease. According to Professor Christian Holscher of Lancaster University and the lead scientist of the study, drugs for type 2 diabetes were continuously tested in…